Exhibit 31.1

Certification
Pursuant to Section 302 of the Sarbanes Oxley Act of 2002

I, Jyotindra
Gange, the Principal Executive Officer of Synovics Pharmaceuticals Inc., a
Nevada corporation (the Registrant), certify that:

1. I have
reviewed this annual report on Amendment No. 1 to Form 10-K of Synovics Pharmaceuticals
    Inc., for the year ended October 31, 2008;

2. Based on my
knowledge, this annual report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this annual report;

3. Based on my
knowledge, the financial statements, and other financial information included
in this annual report, fairly present in all material respects the financial
condition, results of operations and cash flows of the Registrant as of, and
for, the periods presented in this annual report;

4. The
Registrants other certifying officers and I are responsible for establishing
and maintaining disclosure controls and procedures (as defined in Exchange
Act Rules 13a-15 (e) and 15d-15 (e)) and internal control over financial reporting
(as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant
and the Registrant has:

(a) designed
such disclosure controls and procedures, or caused such disclosure controls and
procedures to be designed under our supervision, to ensure that material
information relating to the Registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
during the period in which this report is being prepared;

(b) designed
such internal control over financial reporting, or caused such internal control
over financial reporting to be designed under our supervision, to provide
reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with
generally accepted accounting principles;

(c) evaluated
the effectiveness of the Registrants disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this
report based on such evaluation; and

(d) disclosed
in this report any change in the Registrants internal control over financial
reporting that occurred during the registrants most recent fiscal quarter that
has materially affected, or is reasonably likely to materially affect, the
registrants internal control over financial reporting;

5. The
Registrants other certifying officers and I have disclosed, based on our most
recent evaluation, to the Registrants auditors and the audit committee of
Registrants board of directors (or persons performing the equivalent
function):

a) all
significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to
adversely affect the Registrants ability to record, process, summarize and
report financial data; and

b) any fraud,
whether or not material, that involves management or other employees who have a
significant role in the Registrants internal control over financial reporting.

|                     |     |                              | 
|-------------------- | --- | ---------------------------- | 
|Date:
 June 11, 2009 | /s/ | Jyotindra
 Gange             | 
|                     |     |                              | 
|                     |     | Jyotindra
 Gange,            | 
|                     |     | Principal
 Executive Officer | 

---